Skip to main content
Black Friday Sale - Get 40% off Vantage
Published loading...Updated

Competition Bureau investigation into WELL Health is not a concern, Stifel says

Summary by Cantech Letter
Stifel analyst Justin Keywood, in a Nov. 25 update, maintained his “Buy” rating and C$9.00 target on WELL Health Technologies (WELL Health Technologies Stock Quote, Chart, News, Analysts, Financials TSX:WELL) following a Globe and Mail report that the Competition Bureau has opened an investigation into the company’s AI transcription and electronic medical records software. Keywood […] Source
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Cantech Letter broke the news in on Tuesday, November 25, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal